Brian Gallagher, Jr.

@bmgallagherjr

Healthcare VC building biotech companies, organic chemist, fisherman, runner, fan of all things Boston, faithful Michigan alum

Boston, MA
Vrijeme pridruživanja: prosinac 2012.

Tweetovi

Blokirali ste korisnika/cu @bmgallagherjr

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @bmgallagherjr

  1. Prikvačeni tweet

    An incredibly academically naive view on . Most boards will encourage management to publish when it makes sense but often it’s competition enabling. Investors bet billions on health-care start-ups with paltry publication records

    Poništi
  2. Awesome string and commitment by you Chris.

    Poništi
  3. 1. velj

    The DNA of a Life Science Entrepreneur · BioBuzz

    Poništi
  4. 1. velj

    Hey not sure if you are watching this vs game but got to say the calls seem pretty one sided! (Yes I’m biased)

    Poništi
  5. 1. velj

    More evidence of the importance of microglia in neurodegeneration Microglia take control

    Poništi
  6. 1. velj

    I’m not an alarmist but this shit is scary. Live Map Lets You See The Startling Rise Of The Coronavirus Outbreak via :

    Poništi
  7. 27. sij

    Oft overlooked but very important operational details to running any successful business The Little Things That Make Employees Feel Appreciated

    Poništi
  8. 27. sij

    Not an easy question & depends upon the situation & stage of the company. Nice article by The suburbs are cheaper, but they don’t have what Kendall Square has for biotechs: serendipity

    Poništi
  9. 24. sij

    For all my fellow chemistry nerds Total synthesis reveals atypical atropisomerism in a small-molecule natural product, tryptorubin A

    Poništi
  10. 24. sij

    An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

    Poništi
  11. proslijedio/la je Tweet
    24. sij
    Odgovor korisniku/ci

    Lita Nelsen always used to make this point. "Everyone says that doing BD at places like MIT is answering the phone." But she went on to say that even with everything that they licensed, it didn't even make a dent on the overall budget.

    Poništi
  12. 24. sij

    Further to the discussion had here a couple of weeks ago... Think universities are making lots of money from inventions? Think again. - The Washington Post

    Poništi
  13. 23. sij
    Poništi
  14. 21. sij

    Congratulations to Horizon Pharma and the former River Vision teams! FDA approves first treatment for thyroid eye disease

    Poništi
  15. 15. sij

    Tues night of and third reception without name tags. When did this practice take root? Kinda defeats the purpose of a networking event.

    Poništi
  16. 13. sij
    Poništi
  17. 11. sij

    Presentation of the Rising Star Award by CEO to Jo Varshney founder & CEO VeriSIM Life

    Poništi
  18. 11. sij

    Excellent panel East/West CEO conference leading up to on Asian Markets & Investing in western markets

    Poništi
  19. proslijedio/la je Tweet
    10. sij

    Portfolio News: Jasper Therapeutics expands Series A financing, bringing total fundraising to >$50M. Developing JSP191, an anti-CD117 Ab designed to replace chemo-/radiation therapy for conditioning ahead of curative stem cell & gene therapy

    Poništi
  20. proslijedio/la je Tweet
    9. sij
    Poništi
  21. 7. sij

    In a trial run by SFJ and way ahead of schedule!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·